Chatterjee And Dolor In NEJM Publication
Though vitamin D is crucial for bone health, there continues much debate about other health outcomes. Observational studies have suggested an association between a low 25-hydroxyvitamin D level and the risk of type 2 diabetes.
Vitamin D - no defense against T2D
Study Suggests ICU Care May Be Overutilized In Stable Stemi Patients
A study led by Dr. Jay S. Shavadia published in Journal of the American College of Cardiology: Cardiovascular Interventions showed that although more than 80% of stable patients with an ST-elevation myocardial infarction (STEMI) were treated in the intensive care unit (ICU), the risk of developing a complication requiring ICU care was around 16%. These findings suggest that implementing a risk-based triage strategy could be a better alternative to the current strategy where patients with STEMI are typically admitted to the ICU.
Harold G. Koenig, MD, MHSC To Lead “The Book Of Life” End Of Life Care Training For Faith Leaders And Physicians
Nationally known authority on spirituality, health and loss, Harold G. Koenig, M.D., will lead “The Book of Life,” an all-day training conference to equip area faith leaders and medical providers in offering end-of-life care, scheduled for Tuesday, April 2, at the UTC University Center.
Originally for clergy and faith leaders, this year’s conference has been expanded to included health care providers, and will provide continuing medical education for physicians.
Some Heart Disease, A-Fib Patients On Combined Therapies Could Skip Aspirin
In a finding that suggests less is more, researchers led by the Duke Clinical Research Institute (DCRI) found that the drugs apixaban and clopidogrel -- without aspirin -- comprise the safest treatment regimen for certain patients with atrial fibrillation (A-fib).
The finding -- which applies specifically to patients with A-fib who have had a heart attack and/or are undergoing percutaneous coronary intervention -- should reassure clinicians and patients that dropping aspirin results in no significant increase in ischemic events such as heart attacks, strokes and blood clots.
Naggie Named Associate Dean For Clinical Research Initiatives And Regulatory Affairs
Dean Mary Klotman recently announced that Susanna Naggie MD, associate professor of medicine and 2015 CRTP graduate will be named associate dean for clinical research initiatives and regulatory affairs for the School of Medicine, effective as of February 1, 2019. In this role, Dr. Naggie will provide strategic vision as well as oversight of the Clinical Research Units (CRUs), Office of Regulatory Affairs and Quality, Institutional Review Board (IRB), and Duke Health Data & Specimen Repository.
Simon Gregory Moderates Panel On Gene-Editing Human Embryos
Scientific Uproar Was The Response When Dr. He Jainkui Announced That He Had Created The World’S First Babies Genetically Edited With Crisper.
Last month the world found out for the first time via an Associated Press article that Dr.
Alumni In The News – Jorge Antonio Gutierrez, MD, MHSc
Does The Presence Of Polyvascular Disease Affect The Risk Of Ischemic Events, Both Cardiac And Limb, And Bleeding In Patients With Peripheral Artery Disease (Pad)?
Alumni (2012) Antonio Gutierrez recently published findings in JAMA Cardiology November 2018 “Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial” that from a secondary analysis of a randomized clinical trial of 13,885 patients with peripheral artery disease randomized to receive ticagrelor or clopidogrel compared with patients with